Adinazolam (marketed under the brand name Deracyn) is a benzodiazepine derivative and more specifically a triazolobenzodiazepine (TBZD). It possesses anxiolytic anticonvulsant sedative and antidepressant properties. Adinazolam was developed by Dr. Jackson B. Hester who was seeking to enhance the antidepressant properties of alprazolam which he also developed. Adinazolam was never FDA approved and never made available to the public market.
This page contains content from the copyrighted Wikipedia article "Adinazolam"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
